Paper8971064
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
Clark LC and 15 others. JAMA, 1996. Cited by 1,833 papers, by iCite.
Cite this record
ConductScience Library. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Papers, record 8971064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8971064
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticarcinogenic Agents | Major topic |
| Basal Cell Carcinoma | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Selenium | Major topic |
| Skin Neoplasms | Major topic |
| Adult | |
| Aged | |
| Double-Blind Method | |
| Female | |
| Food, Fortified | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasms | |
| Proportional Hazards Models | |
| Survival Analysis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01-CA42334 | NCI NIH HHS | United States | R01CA042334 | PubMed and NIH | NIH RePORTER |
| R01-CA49764 | NCI NIH HHS | United States | R01CA049764 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04014283 | Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. | Background |
Source ClinicalTrials.gov
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8971070 | Selenium and cancer prevention. Promising results indicate further trials required. | https://conductscience.org/library/papers/8971070 | PubMed |
| Comment in | 9062317 | Selenium supplementation and cancer rates. | https://conductscience.org/library/papers/9062317 | PubMed |
| Comment in | 9062318 | Selenium supplementation and cancer rates. | https://conductscience.org/library/papers/9062318 | PubMed |
| Comment in | 9062319 | Selenium supplementation and cancer rates. | https://conductscience.org/library/papers/9062319 | PubMed |
Cited by526
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,833 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42893486 | Harnessing Methylselenol (CH3SeH): A Highly Effective Platform for Stimuli-Responsive Delivery With Therapeutic Potential. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42893486 | PubMed |
| 42828152 | Progress on the regulation of colorectal cancer and cardio-oncology by the gut microbiota and nutrients. | Front Immunol | 2026 | https://conductscience.org/library/papers/42828152 | PubMed |
| 42796837 | Biochemical Profile of Limnospira platensis Cultivated Under Elevated CO2 with the Addition of Sodium Selenite. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42796837 | PubMed |
| 42554878 | Armillaria mellea sensu lato and related Armillaria species at the crossroads of taxonomy, ecology, and biotechnology: a multi-dimensional review. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42554878 | PubMed |
| 42351736 | Immunomodulatory and Anti-Inflammatory Effects of Phycocyanin Oligopeptide Combined with Selenium and Zinc in LPS-Induced Mice. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351736 | PubMed |
| 42319481 | Bioactivity assessment of selenium nanoparticles biosynthesized by Akkermansia muciniphila. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42319481 | PubMed |
| 42246346 | Beyond the scalpel: rare and experimental nonsurgical treatments for basal cell carcinoma. | Dermatol Online J | 2026 | https://conductscience.org/library/papers/42246346 | PubMed |
| 42087966 | Scientific Opinion on Dietary Reference Values for selenium. | EFSA J | 2014 | https://conductscience.org/library/papers/42087966 | PubMed |
| 42005748 | Guidance on human health risk-benefit assessment of foods. | EFSA J | 2010 | https://conductscience.org/library/papers/42005748 | PubMed |
| 41719757 | Genetics of selenoproteins and selenoprotein metabolism - An overview of current concepts and emerging aspects. | Redox Biol | 2026 | https://conductscience.org/library/papers/41719757 | PubMed |
| 40933265 | Association between dietary selenium intake and the prevalence of prediabetes in Newfoundland population: a cross-sectional study. | Front Nutr | 2025 | https://conductscience.org/library/papers/40933265 | PubMed |
| 40600186 | Selenium compounds for cancer prevention and therapy - human clinical trial considerations. | Med Rev (2021) | 2025 | https://conductscience.org/library/papers/40600186 | PubMed |
| 40100580 | Development and validation of M2 macrophage-related genes in a prognostic model of lung adenocarcinoma based on bulk RNA and ScRNA datasets. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40100580 | PubMed |
| 39830783 | Advances in Selenium and Related Compounds Inhibiting Multi-Organ Fibrosis. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/39830783 | PubMed |
| 39583421 | Selenium in Surgery. | Cureus | 2024 | https://conductscience.org/library/papers/39583421 | PubMed |
| 39304519 | 50 Years of Organoselenium Chemistry, Biochemistry and Reactivity: Mechanistic Understanding, Successful and Controversial Stories. | Chemistry | 2024 | https://conductscience.org/library/papers/39304519 | PubMed |
| 39285869 | Associations of minerals intake with colorectal cancer risk in the prostate, lung, colorectal, ovarian cancer screening trial. | Front Nutr | 2024 | https://conductscience.org/library/papers/39285869 | PubMed |
| 39073467 | Selenium spatial distribution and bioavailability of soil-plant systems in China: a comprehensive review. | Environ Geochem Health | 2024 | https://conductscience.org/library/papers/39073467 | PubMed |
| 39065104 | Effect of Trace Element Selenium on the Intestinal Microbial Community in Nude Mice with Colorectal Cancer. | Microorganisms | 2024 | https://conductscience.org/library/papers/39065104 | PubMed |
| 38576048 | Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer. | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/38576048 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8971064
GET https://conductscience.org/api/papers/v1/8971064/cited_by?page=2